Dr. Kevin Robert Heinsimer, MD

Dr. Heinsimer practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Heinsimer's NPI, 1386082659, was assigned on June 10, 2013. Dr. Heinsimer graduated from Ohio State College of Medicine in 2013. Dr. Heinsimer holds Florida license ME135392.

Dr. Heinsimer's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Heinsimer's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Heinsimer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heinsimer practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Heinsimer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Heinsimer is board certified in urology by the American Board of Urology. Dr. Heinsimer is licensed in Florida.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Heinsimer treats.

CMS data shows 407 Medicare services from Dr. Heinsimer across 13 procedure codes in 2024, for 196 Medicare patients. Medicare paid $29,854 for them.

CMS counts 196 Medicare patients who saw Dr. Heinsimer in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heinsimer's median patient age at 65, with 37% women.

In 2024, Dr. Heinsimer wrote 231 Medicare Part D claims for 89 patients. 84% of them were for generic drugs. CMS names the drug for 144 of them, across 6 drugs with 11 or more claims each, at $29,553 in total drug cost. In 2023, CMS named 174 claims across 6 drugs.

Dr. Heinsimer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Heinsimer as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Heinsimer, published from 2017 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Practice Patterns, Physicians', Urologic Surgical Procedures, Male and Urology. Dr. Heinsimer has published most often in Int Braz J Urol. Dr. Heinsimer's most frequent co-authors are Lucas Ross Wiegand, MD, Adam Seth Baumgarten, MD and Marawan El Tayeb, MD.

Dmand AI links Dr. Heinsimer to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Rectal Neoplasms, Urethral Stricture and Rectal Diseases. University of South Florida sponsors the most, 2.

CMS Open Payments shows 44 general payments to Dr. Heinsimer from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Verathon Inc. paid the most, $1,800.

Dr. Heinsimer graduated from Ohio State College of Medicine in 2013.

Dr. Heinsimer is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.